KORU Medical Systems, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving KORU Medical Systems, Inc. now
Current reporting with the operating signal separated from the noise.
KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript
Investors are testing whether KORU Medical Systems, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
The story matters when it changes KORU Medical Systems, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
The story matters when it changes KORU Medical Systems, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
The story matters when it changes KORU Medical Systems, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest KRMD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
KORU Medical Systems, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →